Bayer: receives EMA approval

(CercleFinance.com) - The European Medicines Agency (EMA) has approved the pre-filled syringe for the administration of Eylea 8 mg (114.
3 mg/ml solution for injection) in the European Union.

The new OcuClick pre-filled syringe will provide ophthalmologists with a simple and effective means of accurately administering the 70-microliter dose of Eylea 8 mg for the approved indications of neovascular age-related macular degeneration (wet) and diabetic macular edema (DME).

Germany will be one of the first markets where the pre-filled syringe will be launched.

' 'This simple, easy and precise application method will greatly benefit ophthalmologists and patients, as it will enable fast and accurate treatment,' said University Professor Dr. med Oliver Zeitz, Senior Consultant and Head of the Department of Ophthalmology at the Charité Campus Benjamin Franklin, Berlin, Germany.

'OcuClick offers the physician excellent control, precision and simplicity for the administration of Eylea 8 mg' said Christine Roth, Executive Vice President, Global Product Strategy and Commercialization, and member of Bayer's Pharmaceuticals Executive Team.

Copyright (c) 2024 CercleFinance.com. All rights reserved.